Can-Fite BioPharma Ltd. (CANF) Stock on a Slide After a Robust Monday, Here’s Why

Can-Fite BioPharma Ltd. (CANF), a clinical-stage biopharmaceutical company, has plunged 13.49% during the aftermarket trading session. As a result, CANF stock is trading at $1.86 at the time of the writing. The decline could be attributed to the profit-taking factor after CANF rocketed 69.29% during Monday’s regular trading session and closed the day at $2.15. […]